100 Questions & Answers about Multiple Sclerosis
Professor of Neurology Miller School of Medicine University of Miami Miami Florida William A Sheremata, William A. Sheremata
Jones & Bartlett Publishers, Nov 15, 2010 - Medical - 185 pages
Whether you are a newly diagnosed patient or a loved one of someone with multiple sclerosis, this book offers information and comfort. Completely revised and updated, 100 Questions & Answers About Multiple Sclerosis, Second Edition provides authoritative, practical answers to the most common questions asked by patients. Written by a leading specialist in the treatment of MS, this easy-to-read book is a comprehensive guide to understanding causes, diagnosis, treatment, and much more. Including actual commentary from patients, 100 Questions & Answers About Multiple Sclerosis, Second Edition is an invaluable resource for anyone coping with the medical, psychological, and emotional turmoil of this disease.
What people are saying - Write a review
We haven't found any reviews in the usual places.
PART ONEThe Basics
PART TWOSymptoms of Multiple Sclerosis
PART THREEDiagnosis Identification and Prognosis of Multiple Sclerosis
Other editions - View all
ACTH acute acute disseminated encephalomyelitis adrenal Answers About Multiple antibody approved areas associated attacks Avonex axons baclofen benefit Betaseron bladder body brain and spinal cause chromosome cladribine clinical cognitive common Copaxone cortex criteria demyelination diagnosis disability dose drugs encephalomyelitis erectile dysfunction exacerbations factor fatigue fingolimod function genes genetic glands glatiramer acetate herpes high-dose hormone illness immune reaction immune responses immune system immunosuppression important increased risk infection inflammation infusion interferon interferon-beta interferon-beta-1a Karen’s lesions lymphocytes macrophages monocytes Multiple Sclerosis muscle myelin damage natalizumab nerve fibers nervous system neurologic neurologist neurons occur optic neuritis oral patients person physicians plaques potential primary progressive problems produced progressive disease protein Rebif relapses relapsing–remitting result role sexual Sheremata side effects spasticity spinal cord steroids studies symptoms therapy tissue treatment trials Tysabri urinary vaccine virus viruses white blood cells white matter